Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/20068104

Clin. Cancer Res. 2010 Jan 15 16 2 541-53

Download in:

View as

General Info

PMID
20068104